What Do Fungal Infections Reveal About the Immune System?
Aleksandra BaraćFungal diseases represent natural experiments in human immunology, as clinical phenotypes often mirror specific defects in host defense pathways rather than pathogen virulence. Fungi are ubiquitous, and expression of the disease indicates failure of immune tolerance, barrier integrity, or innate-adaptive cross talk.
Persistent mucocutaneous or gastrointestinal candidiasis is an indicator of impaired IL-17 immunity. STAT3 signaling abnormalities, gain-of-function mutations in STAT1, AIRE deficiency, or CARD9 mutations interrupt Th17 differentiation and IL-17/IL-22–mediated epithelial defense, thereby resulting in decreased antimicrobial peptide release and impaired neutrophil recruitment. These findings support the function of mucosal immunity and pattern recognition receptor signaling for antifungal defense.
In contrast, the high fungus-specific IgM or IgE responses, especially in allergic bronchopulmonary aspergillosis (ABPA) or allergic fungal rhinosinusitis (AFRS), result from immune hyperreactivity, not invasion. A Th2-stratified cytokine milieu (IL-4, IL-5, and IL-13) favors class-switch recombination, eosinophilic inflammation, and immune complex development, revealing perturbed adaptive immunity despite preserved fungal containment.
Because Aspergillus-specific IgG antibodies represent a key in chronic pulmonary aspergillosis (CPA), they suggest persistent antigenic activation in the lungs with structurally impaired pulmonary integrity and incomplete immune clearance. Here, local immune deficiency and decreased macrophage-neutrophil function coordination enable a context of persistent infection despite angioinvasion. When the innate immune response fails, invasive fungal infections develop. Neutropenia, chronic granulomatous disease (a defect in NADPH oxidase), CARD9 deficiency, or dysfunction of Dectin-1 signaling impair fungal killing and cytokine amplification, allowing angioinvasion and dissemination. Galactomannan or mannan, circulating fungal antigens, reflect unchecked hyphal growth in the context of innate immune failure.
So, fungal infections constitute immunological phenotyping tools: Th17 deficiency causes mucocutaneous disease; Th2 overactivation leads to allergic manifestations; chronic inflammation is a sign of incomplete containment; and innate immune failure lets infection in. Knowing these mechanistic patterns is key for immunologically informed diagnosis and management of primary and secondary immunodeficiencies.